Candidates / 9867

Solekia Limited9867・Wholesale

Activist stake: Freesia Macross. Of the listed companies with this trait in 2021–22, 1 in 5 was bought in the following four years or so — against 1 in 11 for all listed companies.

Taking every trait together, its score is 1.6x the average — #647 of 3,751. The closest type of deal is management buyout.

Score1.6xvs average; #647 of 3,751
Past, similar score1 in 5were bought (19%)
Closest typeMBO
Price-to-book0.71xmarket value ¥9.1bn

Why it looks like past targets

Score by type of buyer

Typevs average for the type
Buyout by the parent0.1x
Management buyout3.0x
Private equity1.4x
Strategic buyer2.1x

Ownership

Top 10 shareholders

HolderTypeStake
フリージア・マクロス株式会社Activist30.1%
佐々木 ベジIndividual22.1%
INTERACTIVE BROKERS LLCCustodian/nominee5.7%
小林 義和Individual4.4%
竹内 理人Individual3.1%
ヨシダ トモヒロIndividual2.9%
富士通株式会社Company2.7%
ソレキア従業員持株会Employee/partner plan2.3%
小林 英之Individual2.1%
東特塗料株式会社Company1.9%

From the annual report for the year to 2026-03-31. Holder types are assigned by name and can be wrong (for example, a founder’s company can look like an operating company). Annual report (PDF, EDINET)

Key figures

Controlling shareholder (over 50%)
No
Largest corporate holder
2.7%
Founder family (individuals and their companies)
34.6%
Officers
26.9%
Net cash ÷ market value
88%
ROE
14.2%
Equity ratio
53%

Activist filings

Estimated cost = total acquisition funds ÷ shares held, from the latest report (or the previous one if the latest does not state the funds). Trades after the report's base date are not included. Stakes whose reports give no funding figure are left out. Share splits after the report are adjusted using the change in shares outstanding. Costs outside the stock's price range while held (0.8x the monthly low to 1.2x the high) are treated as reporting quirks (e.g. funds not updated after selling) and not shown. Stakes cut below 5% (mostly sold) are left out of the totals.

This site ranks listed companies by how closely their public filings (annual reports and large-shareholding reports) resemble past tender-offer and MBO targets. It is not a prediction that any company will be bought, is not based on any non-public information, and is not a recommendation to buy or sell. Not investment advice.

Updated 29 Sep 2026 00:48 JST